Related Experiment Video
Updated: Oct 3, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine
1Department of Dermatology, Beaumont Hospital Farmington Hills, Michigan.
Abstract:
Pityriasis rosea is a common, self-limited, papulosquamous eruption, classically presenting along the Langer lines of the skin. We report a clinically typical case of pityriasis rosea that developed following COVID-19 vaccination. As the novel COVID-19 vaccine becomes more widely available during the ongoing COVID-19 pandemic, it is imperative for both patients and clinicians to be aware of its association with the onset of this benign cutaneous eruption.
Related Concept Videos
Cross-reactivity
Vaccinations
Allergic Reactions
Allergic Drug Reactions
Rheumatic Heart Disease I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests

